Navigation Links
Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
Date:8/28/2007

t in ACHIEVE 2/3 is also progressing well, and will be completed later in 2007.

"At the doses we are evaluating in Phase 3, Albuferon requires half as many injections as the pegylated interferons, and Phase 2 results suggest that it may offer efficacy at least comparable to peginterferon alfa-2a, with comparable safety and possibly less impairment of quality of life," said John McHutchison, M.D., Coordinating Center Principal Investigator for both Phase 3 trials, Professor of Medicine, Duke University Medical Center, and Associate Director, Duke Clinical Research Institute, Durham, N.C. "We are pleased with both the quality and the rapid progress of enrollment, and we look forward to continuing the evaluation of Albuferon in Phase 3 trials."

About the Albuferon Phase 3 Development Program

The Albuferon Phase 3 clinical development program includes two randomized, open-label, active-controlled, multi-center, non-inferiority trials -- ACHIEVE 1 and ACHIEVE 2/3 -- to evaluate the efficacy, safety and impact on health-related quality of life of Albuferon in combination with ribavirin versus Pegasys (peginterferon alfa-2a) in combination with ribavirin.

"The rapid pace of ACHIEVE 1 enrollment demonstrates a high level of interest in Albuferon among clinical investigators, as well as the significant need for improved treatment options for patients with chronic hepatitis C," said Mani Subramanian, M.D., Ph.D., Senior Director of Clinical Research, Infectious Diseases, HGS.

Higher doses of Albuferon administered monthly, in combination with ribavirin, will be explored in a separate Phase 2b trial conducted by Novartis, which is expected to begin later in 2007.

About Albuferon

Albuferon is a novel long-acting form of interferon alpha created by HGS using its proprietary albumin fusion technology. Albuferon results from the genetic fusion of human albumin and interferon alpha. Human albumin is the most prevalent naturally occurring bl
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Apollos human proteins boost stem cell research
5. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
9. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... for industry, healthcare and to first responders on the ... results for the fiscal 2013 fourth quarter and year ... at stock market close and will conduct a conference ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
(Date:5/17/2013)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today announced ... Global Healthcare Conference in New York . ... at 11 a.m. Eastern Time. To listen to the live ... Investor Relations section of the Company,s Web site at ... after the event. About Orexigen® Therapeutics Orexigen ...
(Date:5/17/2013)... May 17, 2013   Shareholder rights attorneys  at ... Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a complaint ... Massachusetts .  The complaint alleges that ... Exchange Act of 1934 (the "Exchange Act") between January ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
... ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ACCP) announced ... performed by Access collaborators at two,prominent institutes ... the joint,symposium of the American Association for ... European Organization for Research and Treatment,of Cancer ...
... Cells has Potential to Yield High ... and Therapeutic Products, ST. LOUIS and RICHMOND, Calif., Oct. ... Inc.,(Nasdaq: SGMO ) announced today the publication of data ... human stem,cells. This work represents a significant advance in the ...
Cached Medicine Technology:Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 2Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 3Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 2Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 3Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 4Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 5
(Date:5/20/2013)... comprised over 24,000 Finnish subjects and was led ... a panel of 28 genetic markers improved detection ... disease (CHD) (10-year risk ≥20%) over traditional risk ... important preventive strategy for CHD, because the current ... "The results indicate that genetic markers could be ...
(Date:5/20/2013)... May 20, 2013 BenefitMall, ... employee benefit, payroll products and services and CompuPay, ... are selected as finalists for the 2013 American Business ... of the Year category, and CompuPay is a finalist ... will ultimately be a Gold, Silver or Bronze Stevie® ...
(Date:5/20/2013)... 20, 2013 With the economic recession taking ... of coupons has seen a significant rise. Jessica Hacker proclaims ... coupons one way or the other. However, some people are ... as an ineffective measure to save money. Therefore, in order ... masses about its use, the online classes offered by Jessica ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Dr. Fanny J ... Brilliant, a gentle fractional laser treatment clinically proven to fight ... Clear + Brilliant are designed to prevent and ... + Brilliant can visibly illuminate skin tone, renew and smoothen ... skin, and reduce the appearance of pores. Developed by the ...
(Date:5/20/2013)... SUNDAY, May 19 (HealthDay News) -- Sleep apnea, the ... and subconsciously waking them up, becomes more common as ... possibility that it may somehow cause -- or be ... just yet if you have sleep apnea. The research ... no connection between the two conditions. Still, scientists found ...
Breaking Medicine News(10 mins):Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 3Health News:Online Couponing Classes Offered by Jessica Hacker to Save Hundreds of Dollars 2Health News:Delaware Dermatologist Now Offers Clear + Brilliant Gentle Laser Skin Rejuvenation Treatments 2Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 2Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 3
... The following was,released today by the Democratic National ... cash in Saint Louis today,56,900 uninsured children in Missouri ... will finally say whether he supports,President Bush,s threat to ... week, President Bush is expected to veto a Democratic ...
... that typically fight bacteria, study finds , MONDAY, Oct. ... urban air pollution, shuts down early immune responses in ... vulnerable to bacteria and other foreign invaders, research shows. ... with increased cardiovascular and pulmonary hospitalizations and deaths, but ...
... Team that Provided Critical Services ... to Over 1,000 in 5 ... half of the husband and wife team that makes up La ... usually focus their attention on the dental needs of their North,County ...
... 1 Consumers are more concerned than ever,about the products ... is now more than just an every day routine, it ... Pure & Natural introduces a,new line of personal care products, ... new product line delivers more than just personal,care benefits; it ...
... Mich., Oct. 1 In an effort to,communicate ... it relates to,adult and embryonic stem cell research, ... bishops have launched a monumental,internal statewide education program ... parishes., The Church,s support for adult stem ...
... Cheryl Servais, MPH, RHIA, VP of Compliance and ... for a legal health record, WAYNE, Pa., ... peak performance within Health Information Management (HIM),departments, today ... Officer, Cheryl Servais, MPH, RHIA, authored The Legal ...
Cached Medicine News:Health News:Missouri Children to Mitt Romney: Show Me Your Health Care Priorities 2Health News:San Diego Dentist Haunted by Smiles in Dominican Republic 2Health News:Pure & Natural: Introducing an Effective, Healthy Approach to Personal Care and Beyond 2Health News:Pure & Natural: Introducing an Effective, Healthy Approach to Personal Care and Beyond 3Health News:Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program 2Health News:Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program 3Health News:Precyse Executive Authors New Book, The Legal Health Record 2
... acclaimed GT-CAPTURE digital camera photomicrographic system can ... such as Olympus, Leica, Nikon, and Zeiss, ... transferring images over the Internet easy and ... a performance-proven Nikkor lens. The system records ...
... digital camera photomicrographic system can be mounted ... Olympus, Leica, Nikon, and Zeiss, making building ... over the Internet easy and fast. Featuring ... Nikkor lens. The system records photomicrographic images ...
... Brilliant digital images with advanced ... Stepping) high density imaging technology offers ... up to 12 million output pixels ... enabling enlarged image data for documentation ...
... from Carl Zeiss developed ... microscopy expert. Not only does ... in all image formats, it ... work with the microscope and ...
Medicine Products: